MiNK Therapeutics (6Q40.F) Q2 2026 Earnings

13MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-0.91
-0.76
-0.62
-0.47

Details

Expected EPS
-0.6577571000000001
Actual EPS
N/A
Surprise EPS
0.66
Surprise Percent
+100%

Description

MiNK Therapeutics (6Q40.F) will report earnings of for Q2 2026 on May 13, 2026.

0 Comments

Share your thoughts